Vaxcyte (PCVX) Stock Forecast & Price Target

PCVX$63.37-1.32 -2.04%
BiotechnologyLarge CapGrowth Stock
Compare
Market cap$10.03BEnterprise value$8.29BRevenue (TTM)$0Market positionTop 25%

Score

66
Bullish
Value
57
Quality
40
Growth
100

Vaxcyte, Inc. price target

PCVX
Low$120.00
Average$122.33
High$125.00
Upside vs current price+93.0%

The average target of $122.33 is +93.0% versus the current PCVX price of $63.37.

Vaxcyte, Inc. analyst ratings

RatingAnalysts
Strong buy1
Buy9
Hold1
Sell0
Strong sell0
ConsensusBuy

11 analysts cover PCVX.

Vaxcyte, Inc. EPS and revenue estimates

PCVX shows the next fiscal years with at least three analysts: 2026 EPS $-8.23, 2027 EPS $-6.50. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-8.23$25.00M
2027$-6.50$87.15M

Is Vaxcyte, Inc. a buy or sell?

Of the 11 analysts covering Vaxcyte, Inc., 10 rate it a buy (1 strong buy and 9 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The PCVX consensus label is Buy, beside 10 buy-side ratings and 0 sell-side ratings.

The average target of $122.33 implies +93.0% versus the current price of $63.37.

Those 11 ratings on PCVX are a headcount, and the label on file is Buy.

Reading the Vaxcyte, Inc. forecast

The PCVX targets sit in a narrow band, from $120.00 to $125.00, around an average of $122.33.

Set next to the $63.37 PCVX quote, that average is +93.0%.

Ratings on the Vaxcyte, Inc. cluster: 10 of 11 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.

PCVX targets have not moved much: $122.33 recently, $122.33 across the quarter.

Only 11 analysts cover PCVX, so the average rests on a short list.

Vaxcyte, Inc. forecast questions

What is the PCVX price target?

The published range for PCVX is $120.00 to $125.00, with an average of $122.33. That average is +93.0% versus the current price of $63.37.

Is Vaxcyte, Inc. a buy or sell?

Of the 11 analysts covering Vaxcyte, Inc., 10 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, and the PCVX headcount is 10 buy, 1 hold, and 0 sell.

What is the EPS estimate for Vaxcyte, Inc.?

Analyst EPS estimates for Vaxcyte, Inc.: 2026 $-8.23, 2027 $-6.50.

What is the revenue estimate for Vaxcyte, Inc.?

Analyst revenue estimates for Vaxcyte, Inc.: 2026 $25.00M, 2027 $87.15M.

How many analysts cover PCVX?

11 analysts cover PCVX. Their consensus on PCVX is Buy, across those 11.

PCVX price $63.37 -1.32 -2.04%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener